Careers  |  Sign In  |  Register

Latest in Pathology & Lab Medicine

Reuters Health • The Doctor's Channel Daily Newscast

A second-look at node-negative or DCIS breast pathology worth it

NEW YORK (Reuters Health) – Getting a second opinion of surgical breast pathology often leads to changes that impact treatment in women with node-negative breast cancer or ductal carcinoma in situ (DCIS), clinicians with the British Columbia Cancer Agency (BCCA) in Vancouver have found. In an email to...

Reuters Health • The Doctor's Channel Daily Newscast

Intrapartum group B strep screening by PCR cost-effective

NEW YORK (Reuters Health) – Compared with antenatal vaginal cultures, intrapartum PCR screening for maternal group B streptococcal colonization reduces the rate of neonatal GBS disease, a French study has shown. Furthermore, “When the costs of screening and antibiotic prophylaxis were included, we...

Reuters Health • The Doctor's Channel Daily Newscast

First-void urine not needed for Chlamydia testing

NEW YORK (Reuters Health) – While first-void urine specimens have been used traditionally to test for Chlamydia trachomatis, newer DNA detection methods produce reliable results using midstream specimens, a New Zealand group reports in the January/February issue of the Annals of Family Medicine. “The...